Baxter International | BAX - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 106.93M 14.23M 2026-06
AtriCure USD 81.92M 8.72M 2026-06
Baxter International USD 3.59B 102M 2026-06
Becton, Dickinson and Co. USD 9.4B 897M 2026-06
Boston Scientific USD 6.43B 1.86B 2026-06
Cooper Companies USD 1.8B 209M 2026-03
Dexcom USD 2.36B 133.9M 2026-06
Edwards Lifesciences USD 1.51B 98.9M 2026-06
Fresenius EUR 9.07B 468M 2026-06
Globus Medical USD 479.35M 3.12M 2026-06
Halozyme Therapeutics USD 344.44M 18.77M 2026-06
ICU Medical USD 498.36M 19.54M 2026-06
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 744.2M 56.7M 2026-06
Integra LifeSciences USD 330.88M 15.96M 2026-06
Intuitive Surgical USD 2.58B 65.1M 2026-06
J&J USD 54.9B 2.82B 2026-06
Laboratory Of America USD 2.12B 516.4M 2026-06
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 264.93M 48.06M 2026-06
Quest Diagnostics USD 1.79B 389M 2026-06
Smith & Nephew USD 2.05B 510M 2026-06
Stryker USD 6.68B 369M 2026-06
Tandem Diabetes Care USD 253M 5.05M 2026-06
Teleflex USD 720.38M 7.67M 2026-06
Terumo JPY 413.28B 127.46B 2026-06
Zimmer Biomet Holdings USD 3.01B 149.2M 2026-06